Concepedia

Reduction of oxidative stress and modulation of autoantibodies against modified low‐density lipoprotein after rosuvastatin therapy

Ulrike Resch, Franz Tatzber, Alexandra C. Budinsky, H. Sinzinger

British Journal of Clinical Pharmacology · 2005 · 78 citations · 42 references

DOIFull text

Open access

Abstract

This study provides in vivo evidence that rosuvastatin significantly reduces oxidative stress and has immunomodulatory properties in a dose- and LDL-independent manner.

References

42

Prediction of Coronary Heart Disease Using Risk Factor Categories

Peter W.F. Wilson, Ralph B. D’Agostino, Daniel Levy et al. · Circulation · 1998 · 9.5K citations

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

Paul M. Ridker, Nader Rifai, Michael Clearfield et al. · New England Journal of Medicine · 2001 · 1.6K citations · Full text

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)

Peter H. Jones, Michael H. Davidson, Evan A. Stein et al. · The American Journal of Cardiology · 2003 · 1.4K citations

, , +8

Statins as a newly recognized type of immunomodulator

Brenda R. Kwak, Flore Mulhaupt, Samir Myit et al. · Nature Medicine · 2000 · 1.4K citations

, , +6

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

J T Salonen, H Korpela, R. Salonen et al. · The Lancet · 1992 · 1.3K citations · Full text

, , +10